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increase safety of transcatheter aortic valve
implantation with the CoreValve system
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Summary Regarding the risk of atrioventricular block during the ﬁrst days following
transcatheter aortic valve implantation (TAVI), temporary pacing is required. Conventionalvalve implantation;
Pacemaker;
Complications
transfemoral temporary pacing catheters have several drawbacks including the risk of car-
diac perforation, infection, and the absence of any ﬁxation mechanism. We describe a case
of TAVI procedure with safer temporary pacing, using subclavicular active-ﬁxation pacemaker
electrode and external generator.
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Introduction
Transcatheter aortic valve implantation (TAVI) has shown
great promise in the treatment of severe aortic steno-
sis in patients not eligible for conventional surgery [1]. In
contrast to conventional valve replacement surgery, TAVI
induced inevitable compression of the annulus and surround-
ing structures, including the atrioventricular (AV) node and
its left bundle branch. Requirement of a permanent pace-
maker implantation (PPI) in the short term, rises from 3%
to 6% [2] with conventional surgery, to more than 20% with
the Medtronic CoreValve autoexpandable device (Medtronic,
Irvine, CA, USA) [3,4]. Temporary transfemoral cardiac pac-
ing is consequently recommended regarding the risk of AV
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lock during the 3—5 days following TAVI procedure. Tradi-
ional temporary pacing catheters have several drawbacks
ncluding the risk of cardiac perforation, infection and the
bsence of any ﬁxation mechanism. We describe a case of
AVI procedure with temporary pacing using subclavicular
ctive-ﬁxation pacemaker electrode and external generator.
ase report
n 85-year-old woman was admitted to out hospital for
ymptomatic severe aortic stenosis. This patient was eli-
ible for TAVI procedure because of very high surgical risk
ith a EUROSCORE of 27%. To avoid transfemoral tempo-
ary pacing, we realized the day before valve implantation
safer approach. Using a 7Fr peel-away introducer sheath,
bipolar active-ﬁxation permanent pacing lead was posi-
ioned in the right ventricle under ﬂuoroscopy guidance with
he tip screwed into the apical septum (Fig. 1). The lead
as stitched to the skin using the anchoring sleeve, then
Published by Elsevier Ltd. All rights reserved.
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Figure 1 Active ﬁxation lead is connected to a reusable gen-
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brator secured to the skin with a large occlusive dressing to
aintain sterility.
onnected to a VVI permanent pacemaker which had been
re-programmed bipolar for stimulation and detection (rate
0 bpm, output 5 V). This was secured to the skin with an
cclusive sticking (Fig. 2). We used a desterilized recupera-
ion pacemaker for cost-effectiveness.
The Transfemoral CoreValve prosthesis implantation was
erformed the day after under general anesthesia and has
een previously described [3]. We performed ﬁrst an aortic
alvuloplasty with a NuCLEUS PTV balloon (NuMED, Hopkin-
on, NY, USA), the original device design allows to avoid
apid pacing. After this predilatation a 23-mm prosthesis was
eployed with excellent ﬁnal results. The patient was extu-
igure 2 Chest radiography showing the position of the pacing
ead. The active-ﬁxation screw mechanism and the CoreValve
re visible.
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ated 4 h after procedure and left the coronary care unit
CCU) for a general cardiology ward after 24 h. We observed
o changes in AV conduction and external pace-maker was
emoved at day 5 without any complication.
iscussion
he reported incidence of permanent pacing for new AV
lock can reach more than 20% after TAVI with the CoreValve
ioprosthesis, resulting in the inevitable intrinsic com-
ression of the ﬁbrous skeleton of the heart, including
he conduction system adjacent to the aortic non coro-
ary cusp. However, there is also a signiﬁcant recovery
n electrocardiographic parameters of cardiac conduction
ith time, resulting in a low pacing requirement for
any patients receiving early permanent pacemakers [5].
hese data suggested a prolonged period for temporary
acing to avoid some unjustiﬁed implantation. However,
everal complications may occur with long-term tempo-
ary transfemoral pacing including tamponade, subsequent
isplacement because of the absence of any ﬁxation mech-
nism, infection, or ventricular arrhythmias [6,7]. The
equirement for transfemoral temporary pacing support
ith these potential problems and prolongation of the immo-
ilization of the elderly patient, greatly lowers our threshold
or early permanent pacemaker. The use of active-ﬁxation
lectrode with external pace-maker is probably interesting
n this context. Active ﬁxation lead can be easily positioned
y subclavicular way and connected to a generator with a
igh output in bipolar mode secured to the skin. Although
yocardial perforation using permanent pacing leads has
een reported following pacemaker implantation [8], this
s very uncommon. It allowed moreover rapid ambulation
nd reduced the infection risk. The increased cost of the
lectrode is easily offset by the reduction in complications,
educed CCU stay and potential avoidance of PPI.
The present case described an alternative method to
ransfemoral pacing to lower the risk of complication
nd shorten the length of hospital stay, which potentially
mproves outcome after TAVI in elderly patients.
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